Document:

bion_ex101.htm

EXHIBIT 10.1
  
 SECURITIES PURCHASE AGREEMENT
  
 SECURITIES PURCHASE AGREEMENT, made as of this 12th day of April 2022, by and between Keith Wong, (“Purchaser”) with an address located at 7222 E. Doubletree Ranch Rd, Unit 300, Scottsdale, Arizona 85258, USA and Bionexus Gene Lab Corp (“Seller”) with an address located at Tower B, Vertical Business Suite 10-2, No. 8, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur. The parties referred to hereinabove are sometimes together referred to herein as the “Parties”.
  
 WHEREAS, Seller is the holder of 2,500,000 shares (to sell) (the ‘Common Stock Shares’) of BIONEXUS GENE LAB CORP, a Wyoming corporation (the “Company”). Seller and Purchaser have agreed to the total Purchase Price of One Hundred Fifty Thousand USD (US$150,000**).
  
 WHEREAS, Seller desires to sell and assign to Purchaser, and Purchaser desires to purchase from Seller the common stock shares of the Company;
  
 NOW THEREFORE, for and in consideration of the mutual promises and covenants hereinafter contained, and other good and valuable consideration, the receipt and legal sufficiency of which is hereby acknowledged, the Parties agree to the following:
  
 1. Transfer. Seller hereby irrevocably sells, assigns, and transfers (“Transfer”) to Purchaser and Purchaser does hereby irrevocably purchase from Seller, the common stock shares of Seller for the Purchase Price.
  
 2. Purchase Price. The total Purchase Price shall be US$150,000** payable by bank wire transfer to Seller. The Seller's bank account information is as follows:
  
 [BANK ACCOUNT]
  
 3. Closing. The closing of the transactions contemplated by this Agreement (the “Closing”) shall take place concurrent with the execution hereof, Transfer Agent’s receipt of the selling stock certificate(s) and the payment of the Purchase Price.
  
 4. Proceedings at Closing. All proceedings to be taken and all documents to be executed and delivered by all Parties at the Closing shall be deemed to have been taken, executed and delivered simultaneously, and no proceedings shall be deemed taken nor documents executed or delivered until all have been taken, executed and delivered.
  
 5. Certain Representations and Warranties. Each Party represents and warrants that such Party (a) has the full power and authority to be bound, and intends to be bound by all of the terms and conditions set forth herein and to execute all documents and perform all acts and transactions required hereby; (b) has not entered into any agreements, arrangements or understandings with any third-party, whether orally or in writing, relating to the subject matter hereof and that neither the delivery of this Securities Purchase Agreement, nor the performance of any obligations contemplated by this Securities Purchase Agreement will result in the breach or default under any license, contract, agreement, arrangement or understandings to which he or it is subject; (c) has such knowledge and experience in financial, tax, and business matters so as to enable it/him to utilize the information available to him in connection with the sale of the Note and Warrant and to make an informed investment decision with respect to this Transfer; and (d) is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D of the Securities Acts.
   
 	 
	Page 1 of 5
	

	 

  
 6. Purchaser’s Additional Representations and Warranties. In addition to the representations and warranties set forth in Section 5 above, the Purchaser represents and warrants that:
  
 (a) Restriction on Resale. Purchaser understands that Common Stock Shares have not been and are not being registered under the Securities Act of 1933 or any state securities laws, and may be offered for sale, sold, assigned or transferred, subject to SEC rule 144.
  
 (b) Purchase for Own Account. Purchaser is acquiring the common stock shares for its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered or exempted under the 1933 Act and does not presently have any agreement or understanding, directly or indirectly, with any party to distribute any of the securities.
  
 (c) Reliance on Exemptions. Purchaser understands that the Common Stock Shares being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Seller is relying in part upon the truth and accuracy of, and Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of Seller set forth herein in order to determine the availability of such exemptions and the eligibility of Purchaser to acquire the securities.
  
 (d) No Representations or Warranties. Seller has made no representation or warranty as to the: (i) business, finances and operations of the Company; or (ii) the value of the Common Stock Shares of the Company.
  
 (e) Information. Purchaser and its advisors, if any, have been furnished with all materials relating to the business, finances and operations of the Company. Purchaser and its advisors, if any, have been afforded the opportunity to ask questions of the Company.
  
 (f) Non-Solicitation. Purchaser acknowledges and agrees that the Seller has not solicited the Purchaser to purchase the common stock shares.
  
 (g) Loss of Complete Investment. Purchaser understands that its purchase of the Common Stock Shares involves a high degree of risk and is able to afford a complete loss of such acquisition. Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Common Stock Shares.
  
 (h) No Governmental Review. Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Common Stock Shares or the securities or the fairness or suitability of the investment in the Common Stock Shares or securities nor have such authorities passed upon or endorsed the merits of the offering of the securities.
   
 	 
	Page 2 of 5
	

	 

  
 (k) Legend. All certificates representing Common Stock Shares shall be stamped or imprinted with a legend in substantially the following form (unless deemed effective under prior to the issuance of such said Common Stock Shares):
  
 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144 A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
  
 7. Seller’s Additional Representations and Warranties. The Seller hereby makes the following representations and warranties to the Purchaser:
  
 (a) Ownership. The Seller owns and is conveying to the Purchaser all of its rights, title and interests to the Common Stock Shares, free and clear of all liens, mortgages, pledges, security interests, encumbrances or charges of any kind or description other than pursuant to the securities laws and upon consummation of the transaction contemplated herein good title in 100% of the Common Stock Shares shall vest in the Purchaser. The Seller has owned these common stock shares for over ONE year.
  
 (b) Duly Endorsed. The Seller hereby represents and warrants to the Purchaser that the Common Stock Shares have been duly endorsed upon their transfer to the Purchaser.
  
 (c) Compliance with Securities Law. The Seller purchased the Common Stock Shares for its own account and not with a present view towards the public sale or distribution thereof. except pursuant to sales registered or exempted from registration under the Securities Act of 1933, as amended, (the “Securities Act”).
  
 (d) The Seller hereby acknowledges that the Purchase Price represents the full consideration for the purchase of the Common Stock Shares, and the Seller is not owed any additional form of consideration from the Purchaser, the Company, or its officers, directors, employees, affiliates, or agents.
   
 	 
	Page 3 of 5
	

	 

  
 8. Entire Agreement. This Securities Purchase Agreement contains the entire understanding between the Parties with respect to, and contains all terms and conditions pertaining to, the subject matter hereof. This Securities Purchase Agreement supersedes any prior agreements, arrangements or understandings between the Parties, whether written or oral, relating to the subject matter hereof. No express or implied warranties, covenants or representations have been made concerning the subject matter of this Securities Purchase Agreement unless expressly stated herein. Any prior written or oral negotiations not contained in this Securities Purchase Agreement are of no force or effect whatsoever.
  
 9. No Reliance. In executing this Securities Purchase Agreement, the Parties have not relied and do not rely on any statements, inducements, promises, or representations made by the other Party or their agents, representatives, or attorneys with regard to the subject matter, basis, or effect of this Securities Purchase Agreement, other than as expressly set forth herein.
  
 10. Severability. If any provision of this Securities Purchase Agreement shall be determined to be invalid or unenforceable to any extent, the remainder of the terms and provisions of and undertakings in this Securities Purchase Agreement and the application of such terms, provisions and undertakings shall not be affected and shall be enforced to the greatest extent permitted by law.
  
 11. Legal Representation, The Parties to this Securities Purchase Agreement represent and warrant to the other that he, or it has full opportunity to obtain, or has in fact obtained, the advice of his, or its own legal counsel with respect to this Securities Purchase Agreement and the transactions contemplated thereby.
  
 12. Notice. Any notice or demand required or permitted to be given or made hereunder to or upon either Party hereto shall be deemed to have been duly given or made for all purposes if (a) in writing and sent by (i) messenger or an overnight courier service against receipt, or (ii) certified or registered mail, postage paid, return receipt requested, or (b) sent by telegram. telecopy, telex, e-mail or similar electronic means, to such party at the known communication address(es) first set forth above, or such other address as either Party may at any time, or from time to time, direct by notice given to the other Party in accordance with this paragraph.
  
 13. No Assignment. This Securities Purchase Agreement, and each right, interest and obligation hereunder, may not be assigned by either Party hereto without the prior written consent of the other Party hereto, and any purported assignment without such consent shall be void and without effect.
  
 14. Governing Law; Jurisdiction. This Securities Purchase Agreement shall be governed by the laws of the State of Arizona, without giving effect to principles of conflicts or choice of law. The Parties hereto consent to the exclusive jurisdiction of any state or federal court located within the County of Maricopa, AZ, and irrevocably agree that all actions or proceedings relating to this Securities Purchase Agreement shall be litigated in such courts, and the Parties waive any objection which he or it may have based on improper venue or forum non convents to the conduct of any proceeding in any such court.
   
 	 
	Page 4 of 5
	

	 

  
 15. Survival of Obligations. The rights and obligations of the parties shall survive the execution of this Agreement and the transfer of the Securities to Purchaser and payment by Purchaser therefore.
  
 16. Counterpart Signature; Facsimile. This Securities Purchase Agreement may be signed in counterparts and shall become effective as if executed in a single, complete document upon its execution by the Parties. Facsimile signatures of the undersigned Parties will have the same force and effect as original signatures.
  
 IN WITNESS WHEREOF, the undersigned have executed this Securities Purchase Agreement as of the date indicated on the first page hereof.
  
  
  	  
	 SELLER
 Bionexus Gene Lab Corp
	  

	  
	  
	  
	  

	  
	 By:
	 
	  

	  
	 Name:
	 Chi Yuen (George) Leong
	  

	  
	  
	 President
	  

	  
	  
	  
	  

	  
	 PURCHASER
 Keith Wong
	  

	  
	  
	  
	  

	  
	 By:
	 
	  

	  
	 Name: 
	 Keith Wong
	  

     
 	 
	Page 5 of 5bion_ex102.htm

EXHIBIT 10.2
  
 CONSULTING AGREEMENT
  
 This Consulting Agreement (the "Agreement") is made and entered into as of Apr 15, 2022 (the "Effective Date"), between BIONEXUS GENE LAB CORP (the "Company"), a corporation registered in Wyoming, located at Tower B, Vertical Business Suite 10-2, No. 8, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, and Keith Wong, 7702 E Doubletree Ranch Rd, #300, Scottsdale, AZ 85258 (the “Consultant”).
  
 WHEREAS:
  
 A. The Company and its subsidiaries engage in the various bio-genetic testing and chemical businesses.
  
 B. The Company desires to retain and the Consultant agrees to be retained to provide consulting services to the Company.
  
 Now therefore, in consideration of the premises and mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound hereby, agree as follows:
  
 1. ENGAGEMENT AS A CONSULTANT
  
 1.1 The Company hereby engages the Consultant to provide service for the Company;
  
 2. TERM OF THIS AGREEMENT
  
 2.1 The term of this Agreement shall become effective and begin as of the Effective Date, and shall continue for eighteen (18) months unless this Agreement is earlier terminated or extended in accordance with the terms of this Agreement.
  
 3. CONSULTANT SERVICE
  
 3.1 The Consultant agrees to perform the following services:
  
 	  
	 (a)
	 The Consultant shall assist the Company with the various assignments for the North America operations given by the Company’s Board or its president Chi Yuen (George) Leong.

	  
	  
	  

 3.2 In providing the Consulting Service, the Consultant will:
  
 	  
	 (a)
	 comply with all applicable laws and regulations;

	  
	  
	  

	  
	 (b)
	 not make any misrepresentation or omit to state any material fact that will result in a misrepresentation regarding the business of the Company; and

	  
	  
	  

	  
	 (c)
	 not disclose, release or publish any information regarding the Company without the prior written consent of the Company.

	  
	  
	  

 3.3 The Consultant will at all times be an independent contractor and the Consultant will not be deemed to be an employee of the Company.
  
 4. CONSULTANT FEE
  
 4.1 A monthly fee of US$8,000 per month, payable on the last day of each calendar month by wire transfer each calendar month by wire transfer to the consultant’s bank account.
  
 	 
	1
	

	 

  
 4.2 A total of $20,000** sign on bonus is payable to consultant together with his first month’s fee.
  
 5. REIMBURSEMENT OF EXPENSES
  
 All expenses must be pre-approved by the Company beforehand.
  
 6. TERMINATION
  
 6.1 The Company may terminate this Agreement at any time only upon the occurrence of any of the following events of default (each an “Event of Default”):
  
 	  
	 (a)
	 the Consultant’s committing an act of fraud, theft or embezzlement or other similar willful misconduct;

	  
	  
	  

 6.2 The Company may at its sole discretion terminate this Agreement in the absence of an Event of Default by delivering notice of termination to the Consultant. If the Consultant is terminated without violating 6.1(a), then the Company agrees to pay in one lump sum the remaining unearned compensation for the remaining un-expired period of this agreement to consultant upon notice of termination and pay all legal fees incurred by consultant to enforce this agreement at a later time.
  
 6.3 The Consultant may terminate this Agreement at any time provided a written notice of termination has been delivered to the Company.
  
 6.4 On termination of this Agreement for any reason, all rights and obligations of each party that are expressly stated to survive termination or continue after termination will survive termination and continue in full force and effect as contemplated in this Agreement.
  
 7.0 PROPRIETARY INFORMATION
  
 The Consultant will not at any time, whether during or after the termination of this Agreement for any reason, reveal to any person or entity any of the trade secrets or confidential information concerning the organization, business or finances of the Company or of any third party which the Company is under an obligation to keep confidential, except as may be required in the ordinary course of performing the Consultant Services to the Company, and the Consultant shall keep secret such trade secrets and confidential information and shall not use or attempt to use any such secrets or information in any manner which is designed to injure or cause loss to the Company. Trade secrets or confidential information shall include, but not be limited to, the Company's financial statements and projections, expansion proposals, business plans and details of its business relationships with banks, lenders and other parties not otherwise publicly available.
  
 8.0 RELIEF 
  
 The Consultant hereby expressly acknowledges that any breach or threatened breach by the Consultant of any of the terms set forth in this Agreement may result in significant and continuing injury to the Company, the monetary value of which would be impossible to establish, and any such breach or threatened breach will provide the Company with any and all rights and remedies to which it may be entitled under the law, including but not limited to injunctive relief or other equitable remedies.
  
 9.0 PARTIES BENEFITED; ASSIGNMENTS
  
 This Agreement shall be binding upon, and inure to the benefit of, the Consultant, his heirs and his personal representative or representatives, and upon the Company and its successors and assigns. Neither this Agreement nor any rights or obligations hereunder may be assigned by the Consultant.
  
 	 
	2
	

	 

  
 10.0 NOTICES
  
 Any notice required or permitted by this Agreement shall be in writing, sent by registered or email, return receipt requested, or by overnight courier, addressed to the Board and the Company at its then principal office, or to the Consultant at the address set forth in the preamble, as the case may be, or to such other address or addresses as any party hereto may from time to time specify in writing for the purpose in a notice given to the other parties in compliance with this section. Notices shall be deemed given when delivered.
  
 11.0 GOVERNING LAW
  
 This Agreement shall be governed by and construed in accordance with the laws of Wyoming, USA.
  
 12.0 REPRESENTATIONS AND WARRANTIES
  
 The Consultant represents and warrants to the Company that (a) the Consultant is under no contractual or other restriction which is inconsistent with the execution of this Agreement, the performance of his duties hereunder or other rights of Company hereunder, and (b) the Consultant is under no physical or mental disability that would hinder the performance of his duties under this Agreement, and (c) the Consultant is working as an executive of a software company in the USA.
  
 13.0 MISCELLANEOUS
  
 This Agreement contains the entire agreement of the parties relating to the subject matter hereof. 
   
 This Agreement supersedes any prior written or oral agreements or understandings between the parties relating to the subject matter hereof.
  
 No modification or amendment of this Agreement shall be valid unless in writing and signed by or on behalf of the parties hereto.
  
 A waiver of the breach of any term or condition of this Agreement shall not be deemed to constitute a waiver of any subsequent breach of the same or any other term or condition.
  
 This Agreement is intended to be performed in accordance with, and only to the extent permitted by, all applicable laws, ordinances, rules and regulations. If any provision of this Agreement, or the application thereof to any person or circumstance, shall, for any reason and to any extent, be held invalid or unenforceable, such invalidity and unenforceability shall not affect the remaining provisions hereof and the application of such provisions to other persons or circumstances, all of which shall be enforced to the greatest extent permitted by law.
  
 The headings in this Agreement are inserted for convenience of reference only and shall not be a part of or control or affect the meaning of any provision hereof.
  
 This Agreement replaces and supersedes all other consultant and employment agreements between the Company and the Consultant and any amendments hereto.
  
 COUNTERPARTS This Agreement may be executed in any number of counterparts, copies, fax copies and each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.
  
 	 
	3
	

	 

  
 IN WITNESS WHEREOF, the parties have duly executed and delivered this Agreement as of the date first written above. 
   	 BIONEXUS GENE LAB CORP
	  

	  
	  

	 
	  

	 Chi Yuen (George) Leong
	  

	 President
	  

	  
	  

	 CONSULTANT
	  

	  
	  

	 
	  

	 Keith Wong
 Consultant
	  

   
 	 
	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]